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A B S T R A C T
Short chain fatty acids (SCFA) are end-products of intestinal bacterial fermentation. The concentrations of fer-
mentation metabolites are closely related to the microbial activity that occurs in various digestive compart-
ments. The fermentation products may vary qualitatively and quantitatively, especially within the colon. The
Simulator of the Human Intestinal Microbial Ecosystem (SHIME), an in vitro dynamic and multicompartment
model of the human intestinal tract, can be adapted to mimic the piglet gastrointestinal tract. In this context, a
quantitative method, based on solid phase microextraction gas chromatography coupled to mass spectrometry
(SPME–GC–MS), was developed for the determination of seven short chain fatty acids, i.e. acetic, propionic,
butyric, isobutyric, valeric, isovaleric and hexanoic acids, in samples coming from this experimental in vitro
gastrointestinal model. The advantage of the SPME-GC–MS technique is that the seven compounds could be
determined in a single run, after a simple and rapid sample treatment, without any other extraction than the
automatic SPME. The developed method was validated in accordance to the European and US FDA guidelines
and showed good specificity/selectivity. In addition, limits of detection and quantification ranged from 8 to
72mg L−1 and from 16 to 144mg L−1, respectively. Two internal quality control samples spiked at different
concentrations were analyzed to assess the trueness of the developed method, which ranged between 97.7 and
122.4% of the expected value, for the seven compounds analyzed. The method was successfully applied to
twenty samples coming from a gastrointestinal model, with different inocula. The developed method might be
used as a general method for measuring SCFA in biological samples.
1. Introduction
Short chain fatty acids (SCFA) are end-products of fermentation of
carbohydrates and proteins, from endogenous or diet origin, by the
intestinal bacteria [1]. They consist of saturated aliphatic organic acids
from 2 to 6 carbons, also known as volatile fatty acids (VFA): acetic
(C2), propionic (C3), butyric (C4), isobutyric (iC4), valeric (C5), iso-
valeric (iC5) and hexanoic (C6) acids, with C2, C3 and C4 re-
presenting>95% of the SCFA encountered in colon or faeces [2].
The amount and types of SCFA produced in a healthy individual
depend largely on the substrate availability, the transit time and the
bacterial composition of the microbiota [3]. In the pig gastrointestinal
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tract, microorganisms are in contact with exogenous or undigested
substrate from the distal ileum to the rectum [4,5]. It is expected that
the total concentration in SCFA and the different proportion between
each of the acids vary all along the intestinal tract of a weaned piglet
[6]. Intestinal SCFA content has to be considered as a balance between
the produced and absorbed SCFA [3]. As an example of in vivo profile
for weaned piglet, the ratios 65:25:10 are usually observed in the colon
for C2, C3 and C4, respectively [7,8]. From an “in vitro colon” point of
view, the ratio can be slightly different (60-20-20%) with a total con-
centration in SCFA, higher in vitro than in vivo [9].
The Simulator of the Human Intestinal Microbial Ecosystem
(SHIME), a dynamic in vitro and multicompartment gastrointestinal
model, is a well-established validated human model [10–12]. Its
adaptation to other animal gastrointestinal environments such as piglet
microbial environment is possible through the adjustment of new
parameters that can be validated. Indeed, the pH of the different
compartments can be adapted, in addition to the diet, the temperature
and the intestinal microbiota that is inoculated into the system. The
microbial composition and the metabolic activity of such model have to
be monitored to ensure its stabilization before starting any trial, be-
cause two weeks of stabilization are necessary to reach the stabilization
of the microbiota [10]. As the metabolic activity of microbiota from the
gut can be measured via the SCFA content, the development of an
adapted method measuring produced SCFA in bioreactors is crucial to
monitoring the validation of gastrointestinal models for new animal
species.
The two in vitro pig models described in the literature, namely
PolyFermS [13] and PigutIVM [9], refer to HPLC-UV as a method to
measure the concentrations of SCFA. In this work, the development of a
chromatographic method to quantify SCFA is described. This method is
using a step of solid phase microextraction (SPME) to trap the com-
pounds on a fiber before separation and detection of the volatile com-
pounds by gas chromatography coupled to mass spectrometry (GC–MS).
The developed SPME-GC–MS method has been used to evaluate the
concentration of SCFA from C2 to C6, including isobutyric and iso-
valeric acids, in samples provided by an experimental run of an adapted
SHIME model. The developed method used 2-methylvaleric acid as
internal standard [14].
2. Materials and methods
2.1. Chemical reagents
Acetic acid (99.9% purity), propionic acid (99.8% purity), iso-
butyric acid (99.7% purity), butyric acid (99.6% purity), isovaleric acid
(99.8% purity), valeric acid (99.8% purity), hexanoic acid (99.6%
purity) and 2-methylvaleric (99.9% purity) were obtained from
Sigma–Aldrich (St. Louis, Missouri, USA). Water was of Chromanorm
quality and provided by VWR International (West Chester,
Pennsylvania, USA). Sulfuric acid (95–97% purity) was obtained from
Merck (Darmstadt, Germany).
2.2. Standard solutions
Seven individual stock solutions (1–4.5mgmL−1) were prepared by
dissolving each SCFA standard in HPLC grade water. A pool containing
acetic, propionic, isobutyric, butyric, isovaleric, valeric and hexanoic
acids at a concentration of 0.720, 0.405, 0.080, 0.350, 0.070, 0.240 and
0.160mgmL−1, respectively, was prepared by diluting a specific vo-
lume of each of the stock solutions with HPLC grade water in a 20mL
volumetric flask.
A 0.2mgmL−1 solution of 2-methylvaleric acid was prepared in
water to be used as internal standard (IS). All standard solutions were
stored in glass vials for maximum 6months at +4 °C.
A 0.9M H2SO4 solution was prepared by diluting H2SO4 in water.
2.3. Culture medium
The medium used to feed the gastrointestinal system, called “feed
medium”, was prepared according to Molly et al. [15] to make it closer
to piglet feed: mucin (6.0 g L−1), proteose-peptone (1.0 g L−1), potato
starch (1.0 g L−1), L-cysteine hydrochloride (0.2 g L−1), all from Pro-
digest (Gent, Belgium), and a post-weaning diet (8.0 g L−1). This diet
(ABZDiervoeding, Nijkerk, The Netherlands) contained mainly barley
(30%), soy (29%), wheat (14%), maize (5%) and oat flakes (5%) as raw
materials and was grinded to particles of 250 μm.
The culture medium was prepared in 5 L bottles and then auto-
claved during 35min at 121 °C. Each bottle was then agitated and let
stand for 10min before pumping 4 L of the supernatant. They were
stored in a fridge and the pH was adjusted at 3.0 before being provided
to the first vessel. Pancreatic juice was prepared in 2 L bottles. It con-
tained sodium hydrogen carbonate (2.5 g L−1, VWR Chemicals, Radnol,
Pennsylvania, USA) and pancreatin (0.9 g L−1, ProDigest) (personal
communication of ProDigest). Oxgall (4.0 g L−1, ProDigest) was added.
2.4. Samples used for the validation of the method
Since no Certified Reference Material of SCFA is available in bio-
logical samples, two in-house Quality Controls (QC) samples of “feed
medium” fortified with standard solutions of SCFA at two different le-
vels were used to assess the performance of the developed method.
QC1 contained concentrations of 360mg L−1 of acetic acid,
202.5mg L−1 of propionic acid, 40mg L−1 of isobutyric acid,
175mg L−1 of butyric acid, 35mg L−1 of isovaleric acid, 120mg L−1 of
valeric acid, 80mg L−1 of hexanoic acid. QC2 was containing con-
centrations of SCFA five-time higher than QC1.
The two QCs were analyzed ten times each on different days.
2.5. Sample preparation
Twenty-five microliters of intestinal content were pipetted into a
20mL glass vial. Forty microliters of internal standard at a concentra-
tion of 0.2 mgmL−1, 15 μL of 0.9M sulfuric acid and 920 μL of feed
medium were added. The vial was vortexed and placed on the auto-
sampler of the SPME-GC–MS until analysis.
2.6. SPME-GC–MS parameters
The method used to analyze SCFA was adapted from Bianchi et al.
[14]. SCFA were extracted with a SPME fiber on a Triplus RSH Auto-
sampler (Thermo Fisher Scientific), separated on a Focus GC gas
chromatograph (Thermo Fisher Scientific) using a Supelcowax-10
column (30m×0.25mm, 0.2 μm) (Supelco, Bellefonte, PA, USA) and
analyzed with an ion trap PolarisQ mass spectrometer (Thermo Fisher
Scientific).
SPME conditions were as follows: DVB/CAR/PDMS fiber (Supelco),
agitation temperature 60 °C with an extraction time of 20min.
Temperature and time of desorption had been preliminarily evaluated
and were set at 250 °C and 5min, respectively. Fiber conditioning post-
injection was performed at 270 °C during 10min.
The GC conditions were: inlet: 250 °C; splitless injection; helium as
the carrier gas at constant pressure of 250 kPa; temperature program:
50 °C for 5.5min, followed by an increase of 75 °Cmin−1 to 170 °C for
2min, then 10 °Cmin−1 to 200 °C for 3min; total run time was
15.10min.
The peaks were identified by comparing their mass spectrum and
retention times with those of the corresponding standards. The MS
conditions were: transfer line: 230 °C; ion source: 220 °C; collision en-
ergy: 35 eV; positive ionization mode. The SCFA were detected using
full scan mode in a mass range between 40 and 150 Da in a single
segment window. In each chromatographic run, different ions were
monitored for each SCFA analyzed, which allowed to perform detection
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and quantitative analysis (Table 1).
2.7. Calibration curves
Seven samples of feed medium spiked with the internal standard at
a concentration of 0.2mgmL−1 and with concentrations ranging from
144 to 7200mg L−1 for acetic acid, 81 to 4050mg L−1 for propionic
acid, 16 to 800mg L−1 for isobutyric acid, 70 to 3500mg L−1 for bu-
tyric acid, 14 to 700mg L−1 for isovaleric acid, 48 to 2400mg L−1 for
valeric acid and 32 to 1600mg L−1 for hexanoic acid were extracted
simultaneously with the samples. The concentration range of the cali-
bration curve was chosen to cover the range of concentrations usually
observed for each SCFA analyzed in biological samples coming from the
gastrointestinal model. These seven samples were used to construct the
calibration curves: the response (ratio between each SCFA and the in-
ternal standard peak areas) was plotted versus standard concentrations.
Calibration points were injected before each series of samples and the
extract spiked at a concentration corresponding to the central point of
the calibration curve was injected one more time after all the samples.
The choice of the best regression model was studied using the sta-
tistic F-test, which is also known as Mandel fitting test [16]. A quadratic
regression was used, and no “fit weighting” was applied. The correla-
tion coefficients R2 associated with those curves were higher than 0.99.
It was also established that only one point of the curve can deviate from
the curve by>20% of the corresponding calculated value.
2.8. Confirmation criteria
SCFA were considered as positively identified in samples if the ratio
between the chromatographic retention time of the analyte and that of
the corresponding IS, i.e. the relative retention time (RRT) of the ana-
lyte, corresponded to that of the average retention time of the cali-
bration solutions within a± 0.5% tolerance and the peak area ratio of
the two transitions of the native analytes corresponded to that of the
averaged transition ratio of the calibration solutions within the toler-
ances set by the Commission Decision 2002/657/EC [17].
2.9. Evaluation of SCFA in samples coming from an in vitro piglet
gastrointestinal model
2.9.1. Samples
Samples were obtained during an experimental run of a modified
SHIME model [10]. It consists in a dynamic multi-compartment in vitro
model mimicking a part of the gastrointestinal tract of a piglet. It begins
with a first bioreactor mimicking stomach, duodenum/jejunum, a
second bioreactor for ileum and finally, a third bioreactor for the
proximal colon. The faeces and intestinal content used to inoculate the
system were obtained from a healthy weaned piglet of 35 days old.
After inoculation of the system, a stabilization period of two weeks had
been applied.
2.9.2. Sample collection
Twenty samples of the different liquids of fermentation (2mL) were
collected during the two weeks of stabilization. Two samples were
obtained during the first phase of stabilization of the microbiota (week
1) and three samples were taken at the end of the stabilization period of
the microbiota (week 2).
Just after their collection, samples were centrifuged 2min at
17,000g (Micro Star 17, VWR). Aliquots and supernatants were sepa-
rated. Supernatants were filtered (0.45 μm, Whatman). All extra sam-
ples, aliquots and supernatants were immediately stored at −20 °C
until SPME-GC–MS.
The intervention on the piglet donor was approved by the ethical
committee of the University of Liège (Belgium) – file no 1824 and was
in compliance with European [18] and Belgian [19] regulations gov-
erning the protection of animals used for scientific purposes.
2.10. Statistics
Minitab 17 software (Minitab Inc., USA) was used for statistical
analysis. The normality of data and equality of variances were eval-
uated. A paired sample t-test was performed. Conditions were con-
sidered as statistically significant with p < 0.05.
3. Results and discussion
3.1. Choice of the analytical technique
Historically analyzed by distillation or using a colorimetric method
developed by Montgomery et al. [20] in environmental aqueous sam-
ples, SCFA are determined nowadays in various samples mainly by
HPLC-UV, GC-FID, titrimetric or spectrofluorimetric methods [21].
Those techniques show variations between each other (sample pre-
paration, accuracy, sensitivity …). However, according to Chatterjee
et al. [21], the determination of SCFAs via GC is the most reliable
among the aforementioned methods with regard to LOQ, precision,
accuracy, sample preparation, and volume of the sample required for
measurement.
Nevertheless, it is also well known that the sensitivity and accuracy
of the SPME-based methods are quite influenced by the “matrix effect”
[22,23]. What is more, SPME is based on an equilibrium partition
which means that, after a sufficient time, equilibrium is established
between the solid phase formed by the fiber and the gas or liquid phase,
leading to a non-exhaustive extraction. In order to counterbalance these
weaknesses, an internal standard (2-methylvaleric acid) was added in
every sample analyzed, matrix-matched calibration curves were used
and a two different Quality Control samples were analyzed with every
series of analysis. In addition, compared to other chromatography
methods, the SPME system maintains a cleaner chromatographic
column. Also, the sample is not directly injected in the machine com-
pared to liquid injection, therefore the fiber stays clean and not im-
mersed in the sample. The fiber enables a specific extraction compared
to headspace injection because the volatiles are trapped on the SPME
fiber during the agitation extraction step. Another advantage of the
SPME-GC–MS technique is that the seven compounds could be de-
termined in a single run, after a simple and rapid sample treatment,
without any other extraction than the automatic SPME.
3.2. SPME optimization
The DVB/CAR/PDMS fiber type was chosen because, as specified by
the supplier, it is suitable for the analysis of flavor compounds (volatiles
and semi-volatiles, C3-C20) with low molecular weight (MW 40-275).
Using standard solutions, the suitability of the fiber was confirmed by a
good separation of the eight SCFA (data not shown).
In order to optimize the extraction temperature, different extraction
temperatures applied to the incubation oven (40, 50, 60, 70, 75, 80, 90
Table 1
Retention times (RT, minutes) and mass of ions followed in MS for each com-
pound analyzed (m/z).
Compounds RT (min) Ions (m/z)
1 C2 Acetic acid 8.43 43+60
2 C3 Propionic acid 8.78 56+57
3 iC4 Isobutyric acid 9.11 41+43
4 C4 Butyric acid 9.21 73+55
5 iC5 Iovaleric acid 9.44 87+69
6 C5 Valeric acid 9.87 60+42
7 IS 2-Me-valeric acid (IS) 10.05 74+87
8 C6 Hexanoic acid 10.66 60+73
IS= Internal standard.
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and 100 °C) were tested three times for each volatile fatty acid in-
cluding the internal standard with an extraction time of 15min. Fig. 1A
was then constructed using on the y-axis the average of the chroma-
tographic peak areas and on the x-axis the extracted temperature tested.
The results observed in Fig. 1A show an optimum extraction tempera-
ture of 60 °C for iC5, 70 °C for C2, C3, C4 and IS, 75 °C for C5, 80 °C for
C6, while for iC4 this optimum is at about 50 °C. Since the IS and the
SCFA presented different extraction behaviors depending on the tem-
perature, the temperature of 60 °C was chosen as a compromise for the
8 fatty acids to be analyzed. Consequently, this extraction temperature
will be used to test the extraction time. To optimize this parameter, the
tests were carried out with different extraction times (5, 15, 25, 35, 45
and 60min) at a temperature of 60 °C. Fig. 1B shows that the optimum
extraction time for C5 and C6 is 60min, but a too long extraction time
seems to be not in favor of iC4 and iC5. It is therefore again necessary to
make a compromise between the optimum values observed for each of
the 8 AGV, while keeping in mind that the whole analysis should not
take too much time. The optimum extraction time chosen for all com-
pounds is 20min.
In conclusion, the parameters selected are an extraction tempera-
ture of 60 °C and an extraction time of 20min. Even if the equilibrium
state is not the same for every SCFA at 60 °C, the use of a calibration
Fig. 1. Chromatographic peak areas versus the extracted temperature tested (°C) (A) or versus the extraction time (min) (B) for acetic (C2), propionic (C3), isobutyric
(iC4), butyric (C4), isovaleric (iC5), valeric (C5), hexanoic (C6) acids and 2-methyl-valeric acid, used as internal standard.
C. Douny, et al. Journal of Chromatography B 1124 (2019) 188–196
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curve extracted in the same conditions of time and temperature as a real
sample enables to have reliable results.
3.3. Performances of the SPME-GC–MS analytical method
The developed method to measure fatty acids fulfills the criteria in
accordance to European and US FDA guidelines [17,24]. In the absence
of specific guidelines for SCFA analysis, we used those texts, which
provide guidelines to evaluate the performance of the screening and
confirmatory methods used for organic residues and contaminants
analysis: selectivity, specificity, recovery, reproducibility. Table 2 pre-
sents the validation parameters of the SPME-GC–MS method for the
quantification of 7 SCFA in feed medium.
3.3.1. Selectivity and specificity
The absence of significant peaks was shown in the blank feed
medium (Fig. 2A) and the presence of quantifiable peaks was seen in
the QCs (feed medium spiked with 7 SCFA at 2 different levels of
concentration, Fig. 2B). When a peak was detected in the blanks, it was
shown that the relative retention times and/or the transition ratios
(ratio between the peak area when following one m/z ratio and that
when following another m/z ration for an analyte) did not correspond
to those of the SCFA analyzed here. For the QCs, it was also shown that
the variations of relative retention times and of transition ratios cor-
responded to that of the calibration solution at a tolerance of± 0.5%
for the RRTs, and±10% for the transition ratios of ions with relative
intensities higher than 50% of the base peak [17].
As it can be seen on Fig. 2B, a good separation was achieved for the
eight compounds in a sample of feed medium spiked with the internal
standard at a concentration of 0.2 mgmL−1 and with 2880mg L−1 of
acetic acid, 1620mg L−1 of propionic acid, 320mg L−1 of isobutyric
acid, 1400mgmL−1 of butyric acid, 280mg L−1 for isovaleric acid,
960mg L−1 of valeric acid and 640mg L−1 for hexanoic acid. Some
tailing can be observed for the chromatographic peaks, with acetic acid
peak (8.43min) showing more tailing than the other SCFA due to its
high volatility. The peaks were identified by comparing their mass
spectrum and retention times with those of the corresponding standards
and by quantifying them with specific m/z ratios as shown in Table 1.
3.3.2. Calibration curves
For calibration curves, the quadratic regression provided a good
curve fitting, i.e. with low residue values and correlation coefficients R2
Table 2
Validation parameters of the SPME-GC–MS method for the quantification of 7 SCFA in feed medium. The two values for intermediate precision and recovery are
respective to the two mean introduced concentration values (n= 10).
SCFA Targeted
spiking levels
(mg*L−1)
QC1 - QC2
Mean introduced
concentrations
(mg*L−1)
QC1 - QC2
LOD
(mg*L−1)
LOQ
(mg*L−1)
Intermediate
precision
(RSD, %)
QC1 - QC2
Recovery (%)
QC1 - QC2
Calibration
curve range
(mg*L−1)
Correlation (R2) Calibration curve equations
C2 360.0–1800.0 405.3–1793.1 72.0 144.0 15.1–6.3 112.6–99.6 144–7200 0.9959 y= 0.056+1.264E-04*x+ 4.017E-09*x2
C3 202.5–1012.5 213.2–1020.6 40.5 81.0 5.7–5.7 105.3–100.8 81–4050 0.9966 y= 0.002+2.673E-05*x+ 1.008E-09*x2
iC4 40.0–200.0 43.5–195.4 8.0 16.0 14.9–5.7 108.9–97.7 16–800 0.9970 y=0.003+4.366E-04*x-3.391E-07*x2
C4 175.0–875.0 189.7–870.6 35.0 70.0 7.5–4.7 108.4–99.5 70–3500 0.9972 y=0.036+2.164E-04*x-1.276E-08*x2
iC5 35.0–175.0 42.8–184.1 7.0 14.0 15.3–6.0 122.4–105.2 14–700 0.9972 y=0.001+1.554E-04*x-1.171E-07*x2
C5 120.0–600.0 129.4–595.8 24.0 48.0 6.6–3.8 107.9–99.3 48–2400 0.9986 y= 0.020+1.732E-03*x+ 6.453E-08*x2
C6 80.0–400.0 89.0–392.9 16.0 32.0 6.2–3.5 111.3–98.2 32–1600 0.9985 y= 0.029+1.489E-03*x+ 4.108E-07*x2
C2= acetic acid; C3=propionic acid; iC4= isobutyric acid; C4= butyric acid; iC5= isovaleric acid; C5=valeric acid; C6= hexanoic acid.
y corresponds to the area ratio between SCFA peak and the internal standard peak, x corresponds to the introduced concentration of SCFA (mg*L−1).
Fig. 2. Chromatogram of a sample of feed medium only spiked with the internal standard at a concentration of 0.2mgmL−1 (A) and of a sample of feed medium
spiked with the internal standard at a concentration of 0.2mgmL−1and with 2880mg L−1 of acetic acid, 1620mg L−1 of propionic acid, 320mg L−1 of isobutyric
acid, 1400mg L−1 of butyric acid, 280mg L−1 for isovaleric acid, 960mg L−1 of valeric acid and 640mg L−1 for hexanoic acid (B).
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associated with those curves higher than 0.99 for the 7 SCFA (Table 2).
The minimum value fixed for that parameter was 0.98. It was also es-
tablished that only one point of the curve can deviate from the curve
by>20% of the corresponding calculated value.
3.3.3. Limit of quantification and limit of detection
The limit of quantification (LOQ) was fixed as the content of SCFA
corresponding to the first point of the calibration curve (after checking
that the signal to noise ratio was higher than 10 at that level). The LOQ
were 144, 81, 16, 70, 14, 48 and 32mg L−1, for C2, C3, iC4, C4, iC5, C5
and C6, respectively. The limit of detection (LOD) was set at LOQ/2,
after checking that the signal to noise ratio was higher than 3 at that
level (Table 2).
3.3.4. Recovery and intermediate precision
Two QC samples were analyzed ten times each on different days to
assess the performance of the developed method. QC1 contained con-
centrations of 360mg L−1 of acetic acid, 202.5mg L−1 of propionic
acid, 40mg L−1 of isobutyric acid, 175mg L−1 of butyric acid,
35mg L−1 of isovaleric acid, 120mg L−1 of valeric acid, 80mg L−1 of
hexanoic acid. QC2 was containing concentrations of SCFA five-time
higher than QC1. The estimated recovery and intermediate precision,
corresponding to the inter-day variation of the results, are presented in
Table 2. The intermediate precision is expressed as the relative standard
deviation (RSD). The Commission Decision 2002/657/EC specifies that,
for mass fractions higher than 1mg kg−1, the RSD must be below 16%.
As shown in Table 2, this was the case for the seven SCFA, in the two
QCs analyzed.
Regarding the recovery, the Commission Decision 2002/657/EC
specifies that, for mass fractions higher than 10 μg kg−1, the recovery
should be included in a range between −20% and +10% of the cer-
tified concentration. For QC1, the recovery is a bit exceeding the upper
limit of the permitted range for C2, iC5 and C6 with 112.6, 122.4 and
111.3%, respectively. For QC2, the measured recovery is included in
the permitted range for the 7 SCFA.
3.3.5. Comparison of the developed method with published methods
A summary of the published methods developed for the detection of
SCFA in human or animal intestinal content or faeces by SPME-GC–MS
is presented in Table 3, including the comparison with the method
proposed in this study [25–34]. Medium (290 μL or 250mg) to high
amounts (3 g) of samples of human faeces are analyzed, with or without
the use of a simulator of gastrointestinal tract. In our study, the only
one working with piglet faeces, a small quantity (25 μL) of sample is
used in the simulator of gastrointestinal tract.
When comparing the sample preparation of the different methods,
only four methods (Saa et al. [27], Di Cagno et al. [32], Mill et al. [29]
and our method) propose a very quick and simple sample preparation,
without any vial transfer. According to Table 3, the SPME extraction
time can vary from 20 to 120min.
In our study, as well as in only 3 other studies out of 12 of the
methods referenced in Table 3, a validation of the method used to de-
tect SCFA was performed. The performances of the developed analytical
method were similar to those published by Bianchi et al. [14], Fiori
et al. [30] and Mills et al. [29], with good precision, line arity and
precision. Concerning the sensitivity of the method, the range of con-
centration evaluated in this work was not chosen to be the lowest as
possible but to cover the range of concentrations usually observed for
each SCFA analyzed in biological samples coming from the gastro-
intestinal model.
3.4. Evaluation of SCFA in samples coming from an in vitro piglet
gastrointestinal model
The concentrations of SCFA (mg L−1) contained in each sample
coming from the experimental run on modified SHIME model
inoculated either with fecal material or intestinal content are shown in
Table 4.
During the stabilization phase of fecal material inoculation, the
average total SCFA concentration was always lower in bioreactor mi-
micking ileum, with an average of 3242 ± 108mg L−1, than in bior-
eactor mimicking proximal colon where the average total SCFA content
was 3759 ± 201mg L−1. The same observation was made when the
model was inoculated with intestinal content, where the average total
SCFA concentration in the bioreactor mimicking ileum was of
3159 ± 42mg L−1 while it was 3461 ± 246mg L−1 in the bioreactor
mimicking proximal colon. Anyway, those differences were not statis-
tically significant, with p=0.069 for fecal material inoculation and
p=0.195 for intestinal content inoculation, respectively. When com-
paring the total SCFA content from ileum and proximal colon, whatever
the inoculum chosen, the difference was statistically significant with
p=0.012.
Regarding the stabilization phases, the SCFA concentrations mea-
sured were not used for any further calculation but were only used to
assess the stability of the system.
In addition to the total SCFA concentrations of the samples, the
importance of each acid in the profile, in terms of concentration, must
be considered. Acetic acid presented the highest concentrations com-
pared to any other SCFA. This is consistent with the literature and the
published in vitro models [9,14,35]. This compound presented a great
variability of concentration between samples included in a same group.
For acetic acid, standard deviations were higher in colon samples than
in ileum samples. This was also observed for all the others except iso-
butyric, isovaleric acids. Regarding hexanoic acid, this was observed
only for the samples obtained when the system was inoculated with real
intestinal content rather than faeces.
Valeric acid was the fourth more present SCFA in the analyzed
samples, following acetic, propionic and butyric acids. Then, after va-
leric acid, isovaleric and isobutyric acids were the two last SCFA that
were present. As seen in vivo, these SCFA were expected to be present as
minor components of the profile, in this order of importance [36].
Regarding hexanoic acid, its concentration in the samples was most of
the time below the limit of quantification of 32mg L−1. However, the
samples obtained from real intestinal content inoculum appeared more
appropriate to measure hexanoic acid concentration in the model with
values ranging from 125 to 348mg L−1.
To compare the range of values obtained with other in vitro models
mentioned in the literature, acid concentrations of samples collected
after the stabilization period were converted in mM, leading to con-
centrations of total SCFA fluctuating between 43 and 56mM. This
model generated lower SCFA concentrations than PolyFermS [13] or
PigutIVM [9] (> 150mM) but the composition of the nutritional
medium added to the model can probably explain this difference. In-
deed, the medium used in the modified SHIME system contained
maximum 16.2 g L−1 of nutrients while the medium from the PigutIVM
contained> 35 g L−1 of carbohydrates and proteins.
4. Conclusions
Regarding the SCFA analyzed, the performance of the method as-
sessed with both QC samples showed good specificity/selectivity and
suitable limits of detection and quantification. Moreover, the measured
concentrations were in accordance to what is found in the literature,
also indicating that the developed method is suitable/convenient for
compounds quantification in samples coming from in vitro gastro-
intestinal models. The average total level of SCFA measured at the end
of the stabilization phase was always lower in ileum bioreactor than in
proximal colon bioreactor. In addition to the total SCFA concentrations
of the samples, the importance of each acid, in terms of profile and
concentration, was assessed and values were in accordance with ex-
pected values.
In conclusion, a specific SPME-GC–MS method for the analysis of
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seven short chain fatty has been developed. The seven compounds
could be determined in a single run, after a simple and fast sample
treatment, without any other extraction than the automatic SPME. The
method was applied with success to different kinds of samples obtained
from a gastrointestinal model mimicking piglet intestinal tract. The
developed method might be used as a general method for measuring
SCFA in biological samples.
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